Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fluconazole (200 mg) + Sodium Chloride (0.9% w/v) infusion
Therapeutic Category
Antifungals
Dosage Form
infusion
Packaging Type
vial
Packaging
100 ml
Price
₹132.35/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fucoziff Infusion is a sterile intravenous formulation combining Fluconazole 200 mg, a potent antifungal agent, with Sodium Chloride 0.9% w/v, serving as the diluent and electrolyte base. Fluconazole belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. This disruption leads to cell membrane damage and death of the fungus. The infusion form ensures rapid and effective systemic absorption, making it suitable for moderate to severe systemic fungal infections, particularly in hospitalized patients.
Commonly reported side effects include nausea, headache, abdominal discomfort, and rash. Rare but serious effects may include hepatotoxicity, QT prolongation, and hypersensitivity reactions. Liver function and cardiac status should be monitored during prolonged therapy.
Fucoziff Infusion is indicated for the treatment of systemic and severe fungal infections, including candidemia, disseminated candidiasis, cryptococcal meningitis, and fungal infections in immunocompromised patients such as those undergoing chemotherapy or organ transplantation. It is also used as a prophylactic antifungal in patients at high risk of fungal infections.
Fucoziff Infusion should be administered only under medical supervision. Dosage adjustments may be necessary in patients with renal or hepatic impairment. Ensure adequate hydration and monitor for infusion site reactions. Do not use in patients with known hypersensitivity to Fluconazole or other azoles.
Store below 25°C. Protect from light and freezing. Use the infusion immediately after opening or as per hospital protocol. Keep out of reach of children.
Composition : Cefuroxime (125mg)
Composition : Cefixime (50mg/5ml)
Composition : Cefixime (50mg) + Ofloxacin (50mg)
Composition : Clarithromycin (125mg)
Composition : Cephalexin (125mg/5ml)
Composition : Cephalexin (250mg/5ml)
Composition : Cefpodoxime Proxetil (100mg) + Clavulanic Acid (62.5mg)
Composition : Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Composition : Amoxycillin (400mg/5ml) + Clavulanic Acid (57mg/5ml)
Composition : Zinc Gluconate 20mg + L. Acidophilus, B. Longum, B. Bifidum, B. Infantis 417mg + Fructo-Oligosaccharide 25mg Pre & Pro Biotic Dry Syrup
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This IV antifungal infusion is used for moderate to severe fungal infections in hospital settings, making it a specialized critical-care and anti-infective hospital product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in hospital ICUs, surgical wards, immunocompromised patient care, and systemic fungal infection management. It is commonly used by physicians in inpatient settings where injectable antifungal therapy is required.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Fluconazole IV Infusion with sodium chloride base with monopoly rights, quality injectable manufacturing standards, competitive pricing, and reliable hospital supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from stable hospital procurement cycles, ICU demand, and repeat usage in fungal infection management when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this IV antifungal formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and institutional distribution support services.